One Dose, Two Years: Psilocybin and Depression in Cancer Patients

Psilocybin for cancer depression: One Dose, Two Years: Psilocybin and Depression in Cancer Patients - The Church of Psychedelics

A single 25 mg dose of psilocybin, given alongside structured psychological support, produced measurable reductions in depression and anxiety that held for up to two years in a group of cancer patients. Those are the findings of a phase 2 trial now published in Cancer, the peer-reviewed journal of the American Cancer Society, and they […]

Healing Is Relational: A Case for Systemic Psilocybin Therapy

Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy.

Most psilocybin research treats healing as something that happens inside one person. A new conceptual article published in Psychedelic Medicine challenges that assumption directly, proposing that the relationships surrounding a person may be just as important to lasting recovery as the medicine itself. Written by Sara N. Lappan and Sean D. Davis of Alliant International […]

Psilocybin Eases Sleep and May Reshape Brain Structure in Chronic Cluster Headache

Psilocybin cluster headache sleep: Psilocybin Eases Sleep and May Reshape Brain Structure in Chronic Cluster Headache - The Church of Psychedelics

A study published in May 2026 reports that psilocybin significantly improved sleep quality in patients living with chronic cluster headache, one of the most debilitating pain conditions known to medicine. The research also observed trends toward changes in white matter microstructure as measured by diffusion-weighted MRI, a finding that is preliminary but points toward a […]

What Six Trials Now Tell Us About Psilocybin for Depression

Psilocybin for depression: What Six Trials Now Tell Us About Psilocybin for Depression - The Church of Psychedelics

A systematic review and meta-analysis published in the Journal of Affective Disorders by researchers at Fujita Health University and Keio University School of Medicine has pooled data from six randomized controlled trials to assess how psilocybin therapy performs against control conditions in treating major depressive disorder (MDD), tracking both efficacy and safety across multiple time […]

Psilocybin for Chronic TBI: One Dose, Three Measurable Effects

Psilocybin for Chronic TBI: One Dose, Three Measurable Effects - The Church of Psychedelics

Months or years after a traumatic brain injury, the brain can remain in a state of low-grade inflammation, serotonin disruption, and persistent behavioral change. Standard care offers little for this chronic phase. A new rat study published in June 2026 suggests that a single dose of psilocybin may be enough to interrupt that prolonged dysfunction, […]

Psychedelic Experience Quality Drives Psilocybin Antidepressant Outcomes

Psychedelic experience quality psilocybin antidepressant outcomes: Psychedelic Experience Quality Drives Psilocybin Antidepressant Outcomes - The Church of Psychedelics

A post hoc path analysis of 79 patients with treatment-resistant depression has found that what happens inside the psilocybin session, specifically the quality of the psychedelic experience, predicts antidepressant outcomes more strongly than the therapeutic alliance formed before dosing. The study, published in July 2026 and drawing on existing trial data, used path analysis to […]

A Standardized Psilocybin Protocol for Depression Passes Its First Real Test

Psychedelic therapy for depression: A Standardized Psilocybin Protocol for Depression Passes Its First Real Test - The Church of Psychedelics

A new pilot trial of psychedelic therapy for major depressive disorder has produced results that researchers describe as showing significant promise, and, perhaps more importantly for the field, the trial was built around a standardized protocol designed to be replicated across clinical settings. If the approach holds up in larger studies, it could mark a […]

One Dose, Weeks of Relief: Psilocybin and Brain Network Restructuring

Psilocybin for depression: One Dose, Weeks of Relief: Psilocybin and Brain Network Restructuring - The Church of Psychedelics

A single dose of psilocybin appears capable of producing sustained relief from depression by restructuring how brain networks communicate with one another. According to reporting by Medical News Today, new findings suggest that the weeks of symptom improvement many patients experience after one psilocybin session are not a simple pharmacological aftereffect but may instead reflect […]

Psilocybin Therapy for Depression: Relief That Lasts Months

Psilocybin therapy for depression: Psilocybin Therapy for Depression: Relief That Lasts Months - The Church of Psychedelics

A clinical study has found that psilocybin therapy may offer sustained relief from depression, with therapeutic effects lasting for months following treatment. The findings add to a growing body of research suggesting that psilocybin, administered in a structured therapeutic context, does not simply produce a temporary shift in mood but may initiate changes that persist […]